Academic Detailing Could Boost Treatment of Tobacco Use

Share this content:
Academic Detailing Could Boost Treatment of Tobacco Use
Academic Detailing Could Boost Treatment of Tobacco Use

(HealthDay News) -- An educational outreach program, academic detailing (AD), can improve the frequency of physicians' performance of simple and complex components of tobacco use treatment, according to a study published in the June issue of the Annals of the American Thoracic Society.

Frank T. Leone, M.D., from the University of Philadelphia, and colleagues examined the influence of a university-based, noncommercial, educational outreach intervention on primary care physicians' treatment practice behaviors. Trained academic detailers visited targeted primary care practices, delivering verbal messages and written instruction highlighting three key tobacco treatment messages. Physicians' treatment behaviors (simple and complex) were assessed using a seven-item questionnaire, administered before and two months after AD.

The researchers observed a significant increase in the mean frequency scores of complex behaviors, from 2.63 to 2.92, corresponding to a 30 percent increase in the number of physicians who "almost always" or "always" endorsed (P < 0.001). There was an improvement in mean simple behavior frequency scores, from 3.98 to 4.13 (P = 0.035). The frequency of complex behavior at baseline was influenced by sex and practice type, while at follow-up, only practice type influenced improvement in complex behavior scores.

"This study demonstrates the feasibility and potential effectiveness of a low-cost and highly disseminable intervention to improve clinician behavior in the context of treating nicotine dependence in underserved communities," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »